A Study of Romosozumab (EVENITY ®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

Conditions: Postmenopausal Osteoporosis Interventions: Drug: Romosozumab Sponsors: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials